nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGER1—pancreas—bile duct cancer	0.0404	0.0652	CbGeAlD
Dinoprostone—SLC51B—liver—bile duct cancer	0.0364	0.0589	CbGeAlD
Dinoprostone—HPGDS—pancreas—bile duct cancer	0.0306	0.0494	CbGeAlD
Dinoprostone—SLC51A—liver—bile duct cancer	0.0261	0.0422	CbGeAlD
Dinoprostone—PTGIR—pancreas—bile duct cancer	0.0249	0.0403	CbGeAlD
Dinoprostone—SLCO2A1—pancreas—bile duct cancer	0.0218	0.0352	CbGeAlD
Dinoprostone—PTGER2—lymph node—bile duct cancer	0.0208	0.0336	CbGeAlD
Dinoprostone—PTGER4—lymph node—bile duct cancer	0.0204	0.0329	CbGeAlD
Dinoprostone—SLCO4A1—pancreas—bile duct cancer	0.02	0.0324	CbGeAlD
Dinoprostone—SLC51A—lymph node—bile duct cancer	0.02	0.0324	CbGeAlD
Dinoprostone—HPGDS—liver—bile duct cancer	0.0195	0.0314	CbGeAlD
Dinoprostone—PTGFR—liver—bile duct cancer	0.018	0.0291	CbGeAlD
Dinoprostone—PTGER3—lymph node—bile duct cancer	0.0173	0.0279	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—bile duct cancer	0.0162	1	CrCbGaD
Dinoprostone—PTGIR—liver—bile duct cancer	0.0159	0.0256	CbGeAlD
Dinoprostone—SLC22A11—liver—bile duct cancer	0.0155	0.025	CbGeAlD
Dinoprostone—SLC22A7—liver—bile duct cancer	0.0151	0.0244	CbGeAlD
Dinoprostone—HPGDS—lymph node—bile duct cancer	0.0149	0.0241	CbGeAlD
Dinoprostone—SLCO3A1—liver—bile duct cancer	0.014	0.0226	CbGeAlD
Dinoprostone—SLCO2A1—liver—bile duct cancer	0.0139	0.0224	CbGeAlD
Dinoprostone—ABCC4—pancreas—bile duct cancer	0.0138	0.0223	CbGeAlD
Dinoprostone—PTGFR—lymph node—bile duct cancer	0.0138	0.0223	CbGeAlD
Dinoprostone—SLCO4A1—liver—bile duct cancer	0.0128	0.0206	CbGeAlD
Dinoprostone—ABCC5—liver—bile duct cancer	0.0127	0.0205	CbGeAlD
Dinoprostone—SLCO1C1—lymph node—bile duct cancer	0.0122	0.0197	CbGeAlD
Dinoprostone—PTGIR—lymph node—bile duct cancer	0.0122	0.0197	CbGeAlD
Dinoprostone—SLCO1B1—liver—bile duct cancer	0.0112	0.0181	CbGeAlD
Dinoprostone—SLCO3A1—lymph node—bile duct cancer	0.0107	0.0173	CbGeAlD
Dinoprostone—SLCO2A1—lymph node—bile duct cancer	0.0106	0.0172	CbGeAlD
Dinoprostone—CYP11A1—lymph node—bile duct cancer	0.0105	0.017	CbGeAlD
Dinoprostone—SLCO2B1—liver—bile duct cancer	0.00993	0.016	CbGeAlD
Dinoprostone—SLCO4A1—lymph node—bile duct cancer	0.00978	0.0158	CbGeAlD
Dinoprostone—ABCC5—lymph node—bile duct cancer	0.00972	0.0157	CbGeAlD
Dinoprostone—SLC22A1—liver—bile duct cancer	0.00949	0.0153	CbGeAlD
Dinoprostone—SLCO1A2—liver—bile duct cancer	0.00913	0.0148	CbGeAlD
Dinoprostone—CYP19A1—liver—bile duct cancer	0.00891	0.0144	CbGeAlD
Dinoprostone—ABCC4—liver—bile duct cancer	0.00879	0.0142	CbGeAlD
Dinoprostone—SLCO2B1—lymph node—bile duct cancer	0.00761	0.0123	CbGeAlD
Dinoprostone—CYP19A1—lymph node—bile duct cancer	0.00683	0.011	CbGeAlD
Dinoprostone—ABCC4—lymph node—bile duct cancer	0.00674	0.0109	CbGeAlD
Dinoprostone—CYP1A2—liver—bile duct cancer	0.00597	0.00965	CbGeAlD
Dinoprostone—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000917	0.00251	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—RNF43—bile duct cancer	0.000913	0.0025	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—FAR2—bile duct cancer	0.000909	0.00249	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—GNAS—bile duct cancer	0.000905	0.00248	CbGpPWpGaD
Dinoprostone—SLC22A11—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000878	0.00241	CbGpPWpGaD
Dinoprostone—ABCC5—NRF2 pathway—TGFB1—bile duct cancer	0.000873	0.00239	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—FAR2—bile duct cancer	0.00086	0.00235	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000857	0.00235	CbGpPWpGaD
Dinoprostone—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000855	0.00234	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—SLC5A5—bile duct cancer	0.000838	0.0023	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—GNAS—bile duct cancer	0.000835	0.00229	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—GNAS—bile duct cancer	0.000822	0.00225	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.000819	0.00224	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000811	0.00222	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.000801	0.00219	CbGpPWpGaD
Dinoprostone—SLC22A7—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000797	0.00218	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—FAR2—bile duct cancer	0.000788	0.00216	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000785	0.00215	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IDH1—bile duct cancer	0.000785	0.00215	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000771	0.00211	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—IDH2—bile duct cancer	0.000765	0.00209	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RNF43—bile duct cancer	0.00076	0.00208	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—GNAS—bile duct cancer	0.000758	0.00208	CbGpPWpGaD
Dinoprostone—SLCO2B1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000753	0.00206	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	0.000746	0.00204	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RNF43—bile duct cancer	0.000744	0.00204	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RNF43—bile duct cancer	0.000744	0.00204	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—FAR2—bile duct cancer	0.000734	0.00201	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	0.00073	0.002	CbGpPWpGaD
Dinoprostone—ABCC5—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00072	0.00197	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—NOS2—bile duct cancer	0.000706	0.00193	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.000705	0.00193	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.00069	0.00189	CbGpPWpGaD
Dinoprostone—SLC22A11—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000682	0.00187	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—IDH2—bile duct cancer	0.00067	0.00183	CbGpPWpGaD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00067	0.00183	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.000667	0.00183	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—IDH1—bile duct cancer	0.000658	0.0018	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—GNAS—bile duct cancer	0.000651	0.00178	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000642	0.00176	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—GNAS—bile duct cancer	0.000624	0.00171	CbGpPWpGaD
Dinoprostone—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000624	0.00171	CbGpPWpGaD
Dinoprostone—SLC22A7—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000619	0.0017	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFBR2—bile duct cancer	0.000613	0.00168	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—GNAS—bile duct cancer	0.000611	0.00167	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—GNAS—bile duct cancer	0.000611	0.00167	CbGpPWpGaD
Dinoprostone—ABCC4—NRF2 pathway—TGFB1—bile duct cancer	0.000605	0.00166	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.000599	0.00164	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000595	0.00163	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—GNAS—bile duct cancer	0.000591	0.00162	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.000586	0.00161	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SMAD4—bile duct cancer	0.00058	0.00159	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—GNAS—bile duct cancer	0.000576	0.00158	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—IDH1—bile duct cancer	0.000576	0.00158	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000573	0.00157	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—GNAS—bile duct cancer	0.000567	0.00155	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000561	0.00154	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000559	0.00153	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—GNAS—bile duct cancer	0.000555	0.00152	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—GNAS—bile duct cancer	0.000555	0.00152	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HGF—bile duct cancer	0.000549	0.0015	CbGpPWpGaD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00052	0.00143	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000519	0.00142	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000509	0.00139	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFBR2—bile duct cancer	0.000503	0.00138	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000499	0.00137	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—IDH2—bile duct cancer	0.000491	0.00134	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—GNAS—bile duct cancer	0.000485	0.00133	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.000483	0.00132	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.000482	0.00132	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SMAD4—bile duct cancer	0.000476	0.0013	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000473	0.0013	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.000473	0.0013	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000466	0.00128	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFBR2—bile duct cancer	0.000464	0.00127	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000462	0.00127	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.000456	0.00125	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—GNAS—bile duct cancer	0.000448	0.00123	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000447	0.00122	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—IDH2—bile duct cancer	0.000444	0.00122	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SMAD4—bile duct cancer	0.000439	0.0012	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000434	0.00119	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000434	0.00119	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000434	0.00119	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—SLC5A5—bile duct cancer	0.000434	0.00119	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—IDH1—bile duct cancer	0.000422	0.00116	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NOS2—bile duct cancer	0.000421	0.00115	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—IDH2—bile duct cancer	0.00042	0.00115	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—NRAS—bile duct cancer	0.000418	0.00115	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFBR2—bile duct cancer	0.000417	0.00114	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.000406	0.00111	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—NRAS—bile duct cancer	0.000404	0.00111	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000395	0.00108	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SMAD4—bile duct cancer	0.000395	0.00108	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—IDH2—bile duct cancer	0.000385	0.00105	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—IDH1—bile duct cancer	0.000382	0.00105	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—EGFR—bile duct cancer	0.000381	0.00104	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—SLC5A5—bile duct cancer	0.00038	0.00104	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00038	0.00104	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TGFB1—bile duct cancer	0.000375	0.00103	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000362	0.000992	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—IDH1—bile duct cancer	0.000361	0.000989	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—KRAS—bile duct cancer	0.00036	0.000986	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—IDH2—bile duct cancer	0.000359	0.000982	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000356	0.000975	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PTGS2—bile duct cancer	0.00035	0.000958	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—KRAS—bile duct cancer	0.000348	0.000953	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFBR2—bile duct cancer	0.000347	0.000951	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FAR2—bile duct cancer	0.000344	0.000941	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—NRAS—bile duct cancer	0.000343	0.00094	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFBR2—bile duct cancer	0.00034	0.000931	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFBR2—bile duct cancer	0.00034	0.000931	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000337	0.000924	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GNAS—bile duct cancer	0.000337	0.000923	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GNAS—bile duct cancer	0.000335	0.000917	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—IDH1—bile duct cancer	0.000331	0.000906	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SMAD4—bile duct cancer	0.000329	0.0009	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GNAS—bile duct cancer	0.000328	0.000898	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GNAS—bile duct cancer	0.000328	0.000898	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ERBB2—bile duct cancer	0.000325	0.000889	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000324	0.000887	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SMAD4—bile duct cancer	0.000322	0.000881	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SMAD4—bile duct cancer	0.000322	0.000881	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—NRAS—bile duct cancer	0.000317	0.000868	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—EGFR—bile duct cancer	0.000313	0.000857	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—bile duct cancer	0.000309	0.000847	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—IDH1—bile duct cancer	0.000308	0.000845	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—HRAS—bile duct cancer	0.000306	0.000838	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—HRAS—bile duct cancer	0.000296	0.00081	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—KRAS—bile duct cancer	0.000295	0.000809	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GNAS—bile duct cancer	0.000295	0.000809	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NOS2—bile duct cancer	0.000294	0.000805	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL6—bile duct cancer	0.000293	0.000802	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—EGFR—bile duct cancer	0.000289	0.000791	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—SLC5A5—bile duct cancer	0.000279	0.000763	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MMP9—bile duct cancer	0.000278	0.000763	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—KRAS—bile duct cancer	0.000273	0.000747	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000269	0.000736	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ERBB2—bile duct cancer	0.000267	0.00073	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000261	0.000715	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—SLC5A5—bile duct cancer	0.000252	0.00069	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—HRAS—bile duct cancer	0.000251	0.000688	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.00025	0.000686	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—NRAS—bile duct cancer	0.000247	0.000676	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ERBB2—bile duct cancer	0.000246	0.000674	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NRAS—bile duct cancer	0.000241	0.00066	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—bile duct cancer	0.00024	0.000658	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—SLC5A5—bile duct cancer	0.000238	0.000652	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—NRAS—bile duct cancer	0.000237	0.000649	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000236	0.000646	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—NRAS—bile duct cancer	0.000232	0.000635	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—NRAS—bile duct cancer	0.000232	0.000635	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—HRAS—bile duct cancer	0.000232	0.000635	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—bile duct cancer	0.000229	0.000629	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MMP9—bile duct cancer	0.000229	0.000626	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EGFR—bile duct cancer	0.000225	0.000616	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—bile duct cancer	0.000224	0.000613	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000223	0.000611	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—bile duct cancer	0.000222	0.000608	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ERBB2—bile duct cancer	0.000221	0.000606	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SLC5A5—bile duct cancer	0.000218	0.000598	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GNAS—bile duct cancer	0.000216	0.000593	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—bile duct cancer	0.000216	0.000592	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—EGFR—bile duct cancer	0.000216	0.000591	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KRAS—bile duct cancer	0.000213	0.000582	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—EGFR—bile duct cancer	0.000211	0.000579	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—EGFR—bile duct cancer	0.000211	0.000579	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—bile duct cancer	0.000211	0.000578	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—KRAS—bile duct cancer	0.000207	0.000568	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—HRAS—bile duct cancer	0.000206	0.000564	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—KRAS—bile duct cancer	0.000204	0.000559	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SLC5A5—bile duct cancer	0.000203	0.000557	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NRAS—bile duct cancer	0.000203	0.000555	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—KRAS—bile duct cancer	0.0002	0.000547	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—KRAS—bile duct cancer	0.0002	0.000547	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GNAS—bile duct cancer	0.000196	0.000536	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—bile duct cancer	0.000192	0.000526	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—bile duct cancer	0.000189	0.000517	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—bile duct cancer	0.000188	0.000516	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NRAS—bile duct cancer	0.000187	0.000513	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNAS—bile duct cancer	0.000185	0.000507	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—bile duct cancer	0.000185	0.000506	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—bile duct cancer	0.000184	0.000505	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB2—bile duct cancer	0.000184	0.000504	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—bile duct cancer	0.000181	0.000496	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—bile duct cancer	0.000181	0.000495	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB2—bile duct cancer	0.00018	0.000493	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB2—bile duct cancer	0.00018	0.000493	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—bile duct cancer	0.000176	0.000483	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—bile duct cancer	0.000175	0.000478	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—bile duct cancer	0.000174	0.000476	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—bile duct cancer	0.000173	0.000475	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—bile duct cancer	0.000173	0.000474	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—bile duct cancer	0.000171	0.000467	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—bile duct cancer	0.00017	0.000465	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—bile duct cancer	0.00017	0.000465	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GNAS—bile duct cancer	0.00017	0.000465	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—bile duct cancer	0.000168	0.000461	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—IDH2—bile duct cancer	0.000168	0.00046	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—bile duct cancer	0.000166	0.000454	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—bile duct cancer	0.000162	0.000445	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—bile duct cancer	0.000162	0.000445	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—bile duct cancer	0.000161	0.000441	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—bile duct cancer	0.000159	0.000434	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNAS—bile duct cancer	0.000158	0.000433	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—bile duct cancer	0.000158	0.000432	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—bile duct cancer	0.000156	0.000428	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—bile duct cancer	0.000155	0.000425	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—bile duct cancer	0.000154	0.000423	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—bile duct cancer	0.000154	0.000423	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—bile duct cancer	0.000153	0.00042	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—bile duct cancer	0.000148	0.000406	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—bile duct cancer	0.000145	0.000397	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—IDH1—bile duct cancer	0.000144	0.000395	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—bile duct cancer	0.000143	0.000392	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—bile duct cancer	0.000142	0.000389	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—bile duct cancer	0.00014	0.000383	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—bile duct cancer	0.000137	0.000375	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—bile duct cancer	0.000137	0.000375	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—bile duct cancer	0.000137	0.000375	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—bile duct cancer	0.000131	0.000359	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—bile duct cancer	0.00013	0.000356	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—bile duct cancer	0.000127	0.000349	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—bile duct cancer	0.000127	0.000349	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—bile duct cancer	0.000127	0.000349	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—bile duct cancer	0.000125	0.000342	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—bile duct cancer	0.000125	0.000342	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—bile duct cancer	0.000123	0.000337	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—bile duct cancer	0.00012	0.00033	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—bile duct cancer	0.000118	0.000323	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—bile duct cancer	0.000118	0.000323	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—bile duct cancer	0.000118	0.000323	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—bile duct cancer	0.000116	0.000318	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—bile duct cancer	0.000107	0.000293	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—bile duct cancer	0.000105	0.000288	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—bile duct cancer	0.000105	0.000287	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—bile duct cancer	0.000105	0.000287	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—bile duct cancer	0.000102	0.00028	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—bile duct cancer	0.0001	0.000275	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—bile duct cancer	0.0001	0.000275	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—bile duct cancer	9.94e-05	0.000272	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—bile duct cancer	9.8e-05	0.000268	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—bile duct cancer	9.59e-05	0.000263	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—bile duct cancer	9.59e-05	0.000263	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC5A5—bile duct cancer	9.52e-05	0.000261	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—bile duct cancer	9.11e-05	0.000249	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	8.92e-05	0.000244	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—bile duct cancer	8.49e-05	0.000233	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNAS—bile duct cancer	7.4e-05	0.000203	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—bile duct cancer	3.97e-05	0.000109	CbGpPWpGaD
